Suzhou To Begin Operation Of Bio-Nano Public Technology Services Platform
This article was originally published in PharmAsia News
Executive Summary
Suzhou Industrial Park has officially put its bio-nano public technology services platform into operation. The base will set up a laboratory with advanced instruments and safety facilities to provide companies with services such as analysis, testing and equipment rental. Enterprises in the industrial park will be able to communicate and collaborate with colleges, academic institutions and device manufacturers to develop value-added services such as training, consulting, academic discussion and joint R&D. SIP places high importance in developing the biopharmaceutical industry in recent years and the platform also forms part of the government's innovative strategy to support high-tech firms. (Click here for more - Chinese Language)
You may also be interested in...
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.